股本结构
单位：万股
| 公告日期 | 2026-08-18 | 2026-08-18 | 2026-06-08 | 2026-06-02 | 2026-05-20 | 2026-04-24 |
|---|---|---|---|---|---|---|
| 证券总股本 | 10063.38 | 8067.12 | 6207.84 | 5995.70 | 5442.85 | 5233.12 |
| 普通股本 | 10063.38 | 8067.12 | 6207.84 | 5995.70 | 5442.85 | 5233.12 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-08-18 | 2026-06-30 | 2026-06-03 | 2026-05-19 | 2026-05-18 | 2026-04-24 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-18 | 10063.38 | 未披露 | 定期报告 | 2026-08-18 |
| 2026-08-18 | 8067.12 | 未披露 |
更多>>
From March 31, 2026 to June 30, 2026
Stock-based compensation - consultants
Stock-based compensation - employees
Shares issued as note extension consideration
Debt exchanges
Proceeds from issuance of common stock, net of issuance costs
Conversion of convertible debt into common stock
|
2026-06-30 |
| 2026-06-08 | 6207.84 | 未披露 | 定期报告 | 2026-06-03 |
| 2026-06-02 | 5995.70 | 未披露 | 定期报告 | 2026-05-19 |
| 2026-05-20 | 5442.85 | 未披露 | 定期报告 | 2026-05-18 |
| 2026-04-24 | 5233.12 | 未披露 | 定期报告 | 2026-04-24 |
| 2026-04-24 | 5261.71 | 未披露 | 定期报告 | 2026-04-23 |
| 2026-04-15 | 5073.82 | 未披露 | 定期报告 | 2026-04-14 |
| 2026-04-15 | 4106.73 | 未披露 |
更多>>
From January 1, 2025 to December 31, 2025
Shares issued pursuant to warrant exchange agreement
Stock-based compensation - consultants
Stock-based compensation - employees
Debt exchanges
Common stock issued as commitment shares to convertible noteholder
Common stock issued as incentive shares to convertible noteholder
Proceeds from issuance of common stock, net of issuance costs
Conversion of convertible debt into common stock
|
2025-12-31 |
| 2025-12-29 | 3743.25 | 未披露 | 定期报告 | 2025-12-22 |
| 2025-12-19 | 3728.17 | 未披露 | 定期报告 | 2025-12-18 |
| 2025-11-07 | 3491.99 | 未披露 | 定期报告 | 2025-11-06 |
| 2025-11-14 | 3186.90 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Common stock issued to consultants
Common stock issued as incentive shares to convertible noteholder
Proceeds from issuance of common stock, net of issuance costs
|
2025-09-30 |
| 2025-09-19 | 3101.39 | 未披露 | 定期报告 | 2025-09-18 |
| 2025-08-18 | 3021.39 | 未披露 | 定期报告 | 2025-08-14 |
| 2025-09-19 | 3071.39 | 未披露 | 定期报告 | 2025-08-06 |
| 2025-08-22 | 3012.74 | 未披露 | 定期报告 | 2025-08-01 |
| 2025-08-18 | 2971.78 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Common stock issued to consultant
Debt exchanges
Common stock issued as commitment shares to convertible noteholder
|
2025-06-30 |
| 2025-06-03 | 2924.17 | 未披露 | 定期报告 | 2025-06-02 |
| 2025-05-15 | 2875.14 | 未披露 | 定期报告 | 2025-05-15 |
| 2025-04-15 | 2728.47 | 未披露 | 定期报告 | 2025-04-15 |
| 2025-05-15 | 2719.81 | 未披露 |
更多>>
From January 1, 2025 to March 31, 2025
Debt exchanges
Shares issued pursuant to warrant exchange agreement
|
2025-03-31 |
| 2025-04-15 | 2360.26 | 未披露 |
更多>>
From January 1, 2024 to December 31, 2024
Debt exchanges
Shares issued pursuant to warrant exchange agreement
Proceeds from exercise of warrants, net of financing fees of $372,109
Proceeds from sale of common stock, net of financing fees of $19,467
Shares issued in lieu of cash
Stock-based compensation
|
2024-12-31 |
| 2025-01-06 | 2325.96 | 未披露 | 定期报告 | 2024-11-20 |
| 2024-11-14 | 2334.60 | 未披露 | 定期报告 | 2024-11-14 |
| 2024-10-28 | 2325.96 | 未披露 | 定期报告 | 2024-10-23 |
| 2024-11-14 | 2325.95 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Shares issued in lieu of cash
Stock-based compensation
Proceeds from exercise of warrants, net of financing fees of $372,109
|
2024-09-30 |
| 2024-10-18 | 2101.40 | 未披露 | 定期报告 | 2024-09-20 |
| 2024-09-05 | 1774.76 | 未披露 | 定期报告 | 2024-08-29 |
| 2024-08-19 | 1783.40 | 未披露 | 定期报告 | 2024-08-19 |
| 2024-08-05 | 1759.08 | 未披露 | 定期报告 | 2024-08-05 |
| 2024-08-19 | 1774.75 | 未披露 | 定期报告 | 2024-03-31 |
| 2024-01-29 | 1693.26 | 未披露 | 定期报告 | 2024-01-29 |
| 2024-08-05 | 1589.60 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Proceeds from sale of common stock, net of financing fees of $442,870
Proceeds from the exercise of warrants, net of financing fees of $275,000
Shares issued in lieu of cash
Shares issued for purchase of customer base
Shares issued for purchase of Cana
Shares issued for purchase of Cloudscreen
Shares issued upon exchange of related party debt
Stock-based compensation
Repurchase of treasury stock
|
2023-12-31 |
| 2023-11-20 | 1340.42 | 未披露 | 定期报告 | 2023-11-20 |
| 2023-11-20 | 1298.22 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Proceeds from sale of common stock, net of financing fees of $442,870
Repurchase of treasury stock
|
2023-09-30 |
| 2023-09-05 | 1306.87 | 未披露 | 定期报告 | 2023-07-21 |
| 2023-07-21 | 1095.18 | 未披露 | 定期报告 | 2023-07-19 |
| 2023-08-15 | 1093.63 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Shares issued for purchase of customer base
Shares issued for purchase of Cana
Stock-based compensation
|
2023-06-30 |
| 2023-04-12 | 1062.07 | 未披露 | 定期报告 | 2023-04-12 |
| 2023-05-16 | 1060.52 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Shares issued in lieu of cash
|
2023-03-31 |
| 2023-01-18 | 1060.54 | 未披露 | 定期报告 | 2023-01-13 |
| 2023-04-12 | 1058.99 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of Series A preferred stock, net of issuance costs of $547,700
Conversion of Series A preferred stock
Sale of common stock
Exercise of warrants
Conversion of notes payable into shares of common stock
Conversion of convertible debt
Cashless exercise of warrants
Shares issued in lieu of cash
Rounding upon reverse stock split of 1 for 25 common shares
|
2022-12-31 |
| 2022-12-21 | 776.13 | 未披露 | 定期报告 | 2022-12-20 |
| 2022-12-15 | 335.19 | 未披露 |
更多>>
Cosmos Holdings Inc. (COSM) will effect a one-for-twenty-five (1-25) reverse split of its common stock and a change of name to Cosmos Health Inc. The reverse split and change of name will be effective at the opening of business on Friday, December 16, 2022.
|
2022-12-16 |
| 2022-11-14 | 8379.75 | 未披露 | 定期报告 | 2022-11-14 |
| 2022-11-07 | 8418.49 | 0.15 | 定期报告 | 2022-10-28 |
| 2022-11-14 | 2597.80 | 0.15 |
更多>>
From June 30, 2022 to September 30, 2022
Conversion of Series A preferred stock
Stock-based compensation
|
2022-09-30 |
| 2022-09-21 | 2636.54 | 未披露 | 定期报告 | 2022-09-16 |
| 2022-08-19 | 2597.80 | 未披露 | 定期报告 | 2022-08-15 |
| 2022-08-19 | 2361.14 | 0.30 |
更多>>
From March 31, 2022 to June 30, 2022
Conversion of Series A preferred stock
Conversion of convertible debt
Cashless exercise of warrants
|
2022-06-30 |
| 2022-05-25 | 1910.66 | 未披露 | 定期报告 | 2022-05-25 |
| 2022-05-17 | 1871.92 | 未披露 | 定期报告 | 2022-05-17 |
| 2022-12-16 | 1754.45 | 未披露 | 定期报告 | 2022-04-15 |
| 2022-05-17 | 1822.46 | 0.60 |
更多>>
From January 1, 2022 to March 31, 2022
Conversion of notes payable into shares of common stock
Cashless exercise of warrants
|
2022-03-31 |
| 2022-02-17 | 1754.45 | 未披露 | 定期报告 | 2022-02-28 |
From March 31, 2026 to June 30, 2026
Stock-based compensation - consultants
Stock-based compensation - employees
Shares issued as note extension consideration
Debt exchanges
Proceeds from issuance of common stock, net of issuance costs
Conversion of convertible debt into common stock
From January 1, 2025 to December 31, 2025
Shares issued pursuant to warrant exchange agreement
Stock-based compensation - consultants
Stock-based compensation - employees
Debt exchanges
Common stock issued as commitment shares to convertible noteholder
Common stock issued as incentive shares to convertible noteholder
Proceeds from issuance of common stock, net of issuance costs
Conversion of convertible debt into common stock
From June 30, 2025 to September 30, 2025
Common stock issued to consultants
Common stock issued as incentive shares to convertible noteholder
Proceeds from issuance of common stock, net of issuance costs
From March 31, 2025 to June 30, 2025
Common stock issued to consultant
Debt exchanges
Common stock issued as commitment shares to convertible noteholder
From January 1, 2025 to March 31, 2025
Debt exchanges
Shares issued pursuant to warrant exchange agreement
From January 1, 2024 to December 31, 2024
Debt exchanges
Shares issued pursuant to warrant exchange agreement
Proceeds from exercise of warrants, net of financing fees of $372,109
Proceeds from sale of common stock, net of financing fees of $19,467
Shares issued in lieu of cash
Stock-based compensation
From June 30, 2024 to September 30, 2024
Shares issued in lieu of cash
Stock-based compensation
Proceeds from exercise of warrants, net of financing fees of $372,109
From December 31, 2022 to December 31, 2023
Proceeds from sale of common stock, net of financing fees of $442,870
Proceeds from the exercise of warrants, net of financing fees of $275,000
Shares issued in lieu of cash
Shares issued for purchase of customer base
Shares issued for purchase of Cana
Shares issued for purchase of Cloudscreen
Shares issued upon exchange of related party debt
Stock-based compensation
Repurchase of treasury stock
From June 30, 2023 to September 30, 2023
Proceeds from sale of common stock, net of financing fees of $442,870
Repurchase of treasury stock
From March 31, 2023 to June 30, 2023
Shares issued for purchase of customer base
Shares issued for purchase of Cana
Stock-based compensation
From January 1, 2023 to March 31, 2023
Shares issued in lieu of cash
From December 31, 2021 to December 31, 2022
Issuance of Series A preferred stock, net of issuance costs of $547,700
Conversion of Series A preferred stock
Sale of common stock
Exercise of warrants
Conversion of notes payable into shares of common stock
Conversion of convertible debt
Cashless exercise of warrants
Shares issued in lieu of cash
Rounding upon reverse stock split of 1 for 25 common shares
Cosmos Holdings Inc. (COSM) will effect a one-for-twenty-five (1-25) reverse split of its common stock and a change of name to Cosmos Health Inc. The reverse split and change of name will be effective at the opening of business on Friday, December 16, 2022.
From June 30, 2022 to September 30, 2022
Conversion of Series A preferred stock
Stock-based compensation
From March 31, 2022 to June 30, 2022
Conversion of Series A preferred stock
Conversion of convertible debt
Cashless exercise of warrants
From January 1, 2022 to March 31, 2022
Conversion of notes payable into shares of common stock
Cashless exercise of warrants